| Model Number |
TV-IL1422120-E |
| Medical Device Problem Code |
Lack of Effect (4065)
|
| Health Effect - Clinical Code |
Clinical Endoleak (4843)
|
| Date of Event |
02/25/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Other text : devices remain implanted.
|
| |
|
Event or Problem Description
|
|
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the ovation prime abdominal aortic aneurysm stent system.Approximately three and a half (3.5) years post initial procedure, the patient presented with a type ib endoeak.The physician elected to treat the patient by implanting one (1) ovation ix extender on (b)(6).The final patient status post secondary intervention is unknown.
|
| |
|
Additional Manufacturer Narrative
|
|
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the reported ovation prime, type ib endoleak (of the right common iliac artery) is unconfirmed.The reported additional endovascular procedure is confirmed.This is moderately consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest a type ii endoleak (site unknown) occurred that was not in the event as reported.This finding was discovered during an examination of discharge summary dated 16 october 2022.Procedure-related harms, device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.The final patient status was not reported.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: h6 investigation finding codes; remove 3233.H6 investigation conclusion codes; remove 11.
|
| |
|
Event or Problem Description
|
|
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the ovation prime abdominal aortic aneurysm stent system.Approximately three and a half (3.5) years post initial procedure, the patient presented with a type ib endoeak.The physician elected to treat the patient by implanting one (1) ovation ix extender on (b)(6) 2019.The final patient status post secondary intervention is unknown.Additional information: clinical assessment identified that a non-device-related type ii endoleak was also present.
|
| |
|
Search Alerts/Recalls
|